Clinical perspectives of PARP inhibitors
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference52 articles.
1. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors;Virag;Pharmacol Rev,2002
2. Role of PARP under stress conditions: cell death or protection?;Nicoletti;Neurochem Res,2003
3. Poly(ADP-ribosyl)ation inhibitors: promising drug candidates for a wide variety of pathophysiologic conditions;Beneke;Int J Cancer,2004
4. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death;Herceg;Mutat Res,2001
5. Poly(ADP-Ribose) Polymerases: Homology, Structural Domains and Functions. Novel Therapeutical Applications;Nguewa;Prog Biophys Mol Biol,2005
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis and In Silico Studies of Quinazolinones as PARP-1 Inhibitors;Combinatorial Chemistry & High Throughput Screening;2023-09-05
2. A Review on Poly (ADP-ribose) Polymerase (PARP) - An Enzyme that Share the ability to Catalyze the Transfer of ADP-Ribose to Target Proteins;Asian Journal of Pharmacy and Technology;2023-08-26
3. Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type;Cancers;2023-04-08
4. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM);Cancers;2023-04-01
5. Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy;Pharmacological Research;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3